Mamintas, Wenilyn .
HRN: 04-44-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
CEFUROXIME 1.5GM (VIAL)
01/16/2024
01/17/2024
IV
1.5g
Q8 X 6 Doses
S/p LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes